Schizophrenia is a severe, lifelong brain disorder. People who have it may hear voices, see things that aren't there or believe that others are reading or controlling their minds. In men, symptoms usually start in the late teens and early 20s. They include hallucinations, or seeing things, and delusions such as hearing voices. For women, they start in the mid-20s to early 30s. Other symptoms include
- Unusual thoughts or perceptions
- Disorders of movement
- Difficulty speaking and expressing emotion
- Problems with attention, memory and organization
No one is sure what causes schizophrenia, but your genetic makeup and brain chemistry probably play a role. Medicines can relieve many of the symptoms, but it can take several tries before you find the right drug. You can reduce relapses by staying on your medicine for as long as your doctor recommends. With treatment, many people improve enough to lead satisfying lives.
As drugs are the mainstay for any type of quality of life, medications are a critical link in how well a schizophrenic will live or not live. Therefore, any news of better medical treatment is encouraging. The event of a new drug deserves headlines.
Aripiprazole is the first available dopamine partial antagonist drug for treating schizophrenia and bi-polar disorder in adults.
Now, a study of this drugs effectiveness in teenagers indicates a successful outcome also. It's makers are seeking FDA approval for treating schizophrenia and bipolar disorder in adults. It is known as an atypical anti-psychotic drug.
This fact is very helpful to know, as drugs do not react the same way in teenagers as adults. Some drugs which are safely used in adults have adverse reactions in teenagers, or are not effective. This study lets physicians know that this drug can safely be used with their teenage patients.
The FDA is considering the fast track for approval.
del.icio.us
Digg this
